ERYZOLE (ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZO) — FDA Approval ANDA062758 (ALRA)
ERYZOLE (ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZO) — FDA Approval ANDA062758 (ALRA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ERYZOLE; Active ingredients: ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL; Application number: ANDA062758.
| Brand name | ERYZOLE |
|---|---|
| Active ingredients | ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL |
| Application number | ANDA062758 |
| Sponsor | ALRA |
| Dosage form | GRANULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19880615 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →